title: Engineering CAR-T cells: Design concepts.
abstract: Despite being empirically designed based on a simple understanding of TCR signaling, T cells engineered with chimeric antigen receptors (CARs) have been remarkably successful in treating patients with advanced refractory B cell malignancies. However, many challenges remain in improving the safety and efficacy of this therapy and extending it toward the treatment of epithelial cancers. Other aspects of TCR signaling beyond those directly provided by CD3ζ and CD28 phosphorylation strongly influence a T cell's ability to differentiate and acquire full effector functions. Here, we discuss how the principles of TCR recognition, including spatial constraints, Kon/Koff rates, and synapse formation, along with in-depth analysis of CAR signaling might be applied to develop safer and more effective synthetic tumor targeting receptors.
authors.affiliation: Program in Immunology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA.
authors.forename: Shivani
authors.initials: S
authors.lastname: Srivastava
authors.affiliation: Program in Immunology, Fred Hutchinson Cancer Research Center, 1100 Fairview Avenue N., Seattle, WA 98109, USA. Electronic address: sriddell@fredhutch.org.
authors.forename: Stanley R
authors.initials: SR
authors.lastname: Riddell
mesh_terms: D000818:Animals; D000951:Antigens, Neoplasm / Q000276:immunology*; D060846:Cell Engineering; D006801:Humans; D011948:Receptors, Antigen, T-Cell / Q000276:immunology* / Q000378:metabolism*; D015398:Signal Transduction / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology* / Q000378:metabolism* / Q000637:transplantation
chemical_list: D000951:Antigens, Neoplasm; D011948:Receptors, Antigen, T-Cell